Alliance Advocates for Equitable Access to Alzheimer’s Treatment

Alliance Board member Jay Reinstein honored by Alzheimer’s Association for advocacy work

Despite Stated Concern, ICER Doesn’t Plan to Make Meaningful Changes to Address Equity

The Institute for Clinical and Economic Review's (ICER) recent report on health equity lacks any meaningful plan to change their value assessment methodology to help incentivize the development of therapeutics that advance equity. 

Read the Alliance’s reaction statement to this report.

Alliance President & CEO Sue Peschin, MHS, delivered public comment at the March 17 ICER meeting on lecanumab for the treatment of early Alzheimer’s.

Podcast: Kick QALY to the Curb
A Conversation with Terry Wilcox of Patients Rising

This month, we welcome back Co-Founder and CEO of Patients Rising, Terry Wilcox to break down the impact of the quality adjusted life year on patients whose quality of life relies on
access to crucial treatments.

Listen to the Podcast

Energy & Commerce Committee Reports QALY Ban Bill for Consideration by U.S. House of Representatives

Study: Many Physicians Know Little About Muscle Loss Condition

New findings in the Journal of the American Geriatrics Society (JAGS) reveal that most physicians aren’t talking about sarcopenia, a condition that accelerates the loss of muscle mass and strength.

Find out what your doctor doesn't know about muscle loss in the latest study led by the Alliance and Aging in Motion,
now available via open access.

Read More

Chairman's Blog:
Vision Changes Worth Looking At 

"Sometime after our 40th birthdays, most of us will get a wake-up call about our vision."

Despite the critical role that our eyes play in navigating the world around us, few of us understand the risks and the steps we need to protect our vision. 

​In the latest Chairman's Blog, Alliance board chair Jim Scott alerts us of the enveloping effects of vision loss as we age and shares resources that may protect your eyes in the future. 

Read More

VIDEO: Alliance President & CEO Sue Peschin, MHS, speaks at the Information Technology and Innovation Foundation’s panel presentation, “Preserving a Virtuous Sycle: The Economics of Biopharmaceutical Innovation.”

Join Our Social Networks